Intec Pharma Announces Topline Results of a Food Effect, Pharmacokinetic Study of AP-CDLD 50/500mg for the Treatment of Parkinson's Disease Symptoms
Go back to Intec Pharma Announces Topline Results of a Food Effect, Pharmacokinetic Study of AP-CDLD 50/500mg for the Treatment of Parkinson's Disease Symptoms| Intel (NASDAQ: INTC) | Delayed: 108.60 -0.2 (0.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $108.80 | 52 Week High | $38.36 | |||
| Open | $109.79 | 52 Week Low | $27.68 | |||
| Day High | $110.49 | P/E | 57.46 | |||
| Day Low | $106.40 | EPS | $1.89 | |||
| Volume | 174,913,047 | |||||
| Neose Technologies, Inc. (NASDAQ: NTEC) | Delayed: 9.63 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.63 | 52 Week High | $6.36 | |||
| Open | $129.86 | 52 Week Low | $3.03 | |||
| Day High | $9.63 | P/E | N/A | |||
| Day Low | $9.63 | EPS | $0.00 | |||
| Volume | 282,816 | |||||
